Released Oct 30, 2017, after the close
10-Q filed Oct 30, 2017, 30 days after period end · 0001564590-17-020382
Q3 2017 · 10-Q
Revenue$105.25M$105.25M +6.9% vs Q3 2016−3.4% vs Q2 2017
Net Income$3.46M$3.46M −65.1% vs Q3 2016−10.3% vs Q2 2017
EPS Diluted$0.19$0.19 −64.8% vs Q3 2016−9.5% vs Q2 2017
Gross Profit$81,530,000+3.7%
Operating Income$9,034,000−2.6%
Operating Cash Flowderived$13,767,000−19.1%
Free Cash Flowderived$9,361,000−31.6%
Margins · derived
Gross margin77.5%−2.4 pt vs Q3 2016
Operating margin8.6%−0.8 pt vs Q3 2016
Net margin3.3%−6.8 pt vs Q3 2016
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Revenue | $105.25M | $98.50M | $101.15M | $100.99M |
| Net Income | $3.46M | $9.90M | -$1.37M | $452.00K |
| EPS Diluted | $0.19 | $0.54 | -$0.07 | $0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR